ImmunityBio, Inc.
IBRX · Biological Products, (No Disgnostic Substances)
Latest available SEC filing: 4 ·
Latest disclosures
-
Simon Barry J.: Form 4
Insider disclosure · Filed · Report period 05 Oct 2026
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Latest financial period: Q2 2026
Financial facts · Filed
-
Form 10-Q
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
-
Form 4
SEC filing · Filed
Institutional holders by security
Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.
- IBRX · 45256X103 - Common Stock, par value $0.0001 per share
Company details and SEC sources
CIK 0001326110 · SEC filing index. Filing dates describe disclosures, not live market data.
- Listed symbols
- IBRX on Nasdaq
- SEC industry group
- Biological Products, (No Disgnostic Substances) (Office of Life Sciences)
- Business address
- 3530 John Hopkins Court, San Diego, CA, 92121
- Incorporated in
- DE
- Fiscal year end
- 31 December
- Former names on EDGAR
- NantKwest, Inc. (to 08 Mar 2021), Conkwest, Inc. (to 13 Jul 2015), ZelleRx Corp (to 09 Oct 2009)
At a glance
Names, identifiers, and filing context for this profile.
2 identity fields